Topical Eutectic Mixture for Premature Ejaculation - Medpharma
Alternative Names: TEMPELatest Information Update: 24 Aug 2004
At a glance
- Originator Medpharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 28 Dec 2003 Discontinued - Phase-II for Premature ejaculation in United Kingdom (Topical)
- 28 Jun 2003 Phase-II clinical trials in Premature ejaculation in United Kingdom (Topical)